Edwards Lifesciences Corp/ US28176E1082 /
| 17.05.2024 22:10:00 | Diff. -0,97 | Volumen | Geld02:00:00 | Brief02:00:00 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 89,14USD | -1,08% | 2,07 Mio. Umsatz: 138,15 Mio. |
87,59Geld Vol: 200 | 92,00Brief Vol: 100 | 53,72 Mrd.USD | - | 38,59 |
Aktiva
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 482,5000 | 580 | 679,7000 | 867,5000 | 1.060,3000 | ||||||
| Immaterielle Vermögensgegenstände | 205,4000 | 204,8000 | 468 | 343,2000 | 336,5000 | ||||||
| Finanzanlagen | 379,9000 | 532,1000 | 567 | 506,3000 | 585,5000 | ||||||
| Anlagevermögen | 2.011,4000 | 2.270 | 3.163,7000 | 3.036,8000 | 3.504,1000 | ||||||
| Vorräte | 339,9000 | 396,6000 | 554,9000 | 607 | 640,9000 | ||||||
| Forderungen | 315,4000 | 365,5000 | 421,6000 | 456,9000 | 543,6000 | ||||||
| Liquide Mitteln | 718,4000 | 930,1000 | 818,3000 | 714,1000 | 1.179,1000 | ||||||
| Umlaufvermögen | 2.047,9000 | 2.240 | 2.532,1000 | 2.286,9000 | 2.984 | ||||||
| Aktiva, gesamt | 4.059,3000 | 4.510 | 5.695,8000 | 5.323,7000 | 6.488,1000 | ||||||
Passiva
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 63,9000 | 97,1000 | 116,6000 | 134 | 180,4000 | ||||||
| Langfristige Schulden | 599,9000 | 822,3000 | 438,4000 | 593,8000 | 594,4000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
| Rückstellungen | 412,3000 | 435,4000 | 636,6000 | 876,6000 | 696,5000 | ||||||
| Verbindlichkeiten | 1.556,2000 | 1.891 | 2.739,6000 | 2.183,3000 | 2.339,8000 | ||||||
| Gezeichnetes Kapital | 717,3000 | 727,8000 | 636 | 645,6000 | 654,3000 | ||||||
| Eigenkapital | 2.503,1000 | 2.619 | 2.956,2000 | 3.140,4000 | 4.148,3000 | ||||||
| Minderheitenanteile | - | - | - | - | - | ||||||
| Passiva, gesamt | 4.059,3000 | 4.510 | 5.695,8000 | 5.323,7000 | 6.488,1000 | ||||||
Gewinn- und Verlustrechnung
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 2.493,7000 | 2.963,7000 | 3.435,3000 | 3.722,8000 | 4.348 | ||||||
| Abschreibungen (Gesamt) | 65,8000 | - | - | - | - | ||||||
| Betriebsergebnis | - | - | 1.089,4000 | 748,2000 | 1.146,8000 | ||||||
| Zinsergebnis | 9,3000 | 8,4000 | 2,9000 | -2,1000 | -11,5000 | ||||||
| Ergebnis vor Steuern | 622,4000 | 737,9000 | 1.034,9000 | 761,4000 | 1.166,5000 | ||||||
| Ertragsteuern | 127,5000 | 168,4000 | 451,3000 | 39,2000 | 119,6000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | - | - | - | - | - | ||||||
| Konzernjahresüberschuss | 494,9000 | 569,5000 | 583,6000 | 722,2000 | 1.046,9000 | ||||||
Pro Aktie
Cash Flow
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 549,7000 | 704,4000 | 1.000,7000 | 926,8000 | 1.179,4000 | ||||||
| Cash Flow aus Investitionstätigkeit | -316,1000 | -211,7000 | -647,2000 | 76,7000 | -595,8000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -158,6000 | -268,5000 | -473,2000 | -1.101,2000 | -115,6000 | ||||||
| Veränderung der liquiden Mittel | 64,6000 | 211,7000 | -111,8000 | -104,2000 | 465 | ||||||
| Anzahl der Mitarbeiter | 9.800 | 11.100 | 12.200 | 12.800 | 13.900 | ||||||
